(SCL) Stepan - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8585861003

SCL: Surfactants, Polymers, Specialty, Chemicals, Detergents, Emulsifiers

Stepan Company, a specialty chemicals manufacturer with a rich history dating back to 1932, operates through three distinct segments: Surfactants, Polymers, and Specialty Products. Each segment is tailored to serve specific industries, making Stepan a pivotal player in the specialty chemicals sector.

The Surfactants segment is the cornerstone of Stepans business, producing surfactants that are integral to consumer and industrial cleaning products. These include detergents for laundry and dishwashing, as well as shampoos and body washes. Beyond personal care, these surfactants find applications in industrial settings, such as in fabric softeners and disinfectants. Their versatility extends to agricultural emulsifiers and industrial latex systems, showcasing their broad utility.

The Polymers segment focuses on polyurethane polyols, essential for manufacturing rigid foam insulation used in construction. This segment also produces polyester resins and phthalic anhydride, which are crucial for coatings, adhesives, and plastics in construction and automotive industries. These products are fundamental to modern manufacturing, contributing to energy efficiency and material durability.

The Specialty Products segment caters to the food, flavoring, and pharmaceutical industries, offering flavors, emulsifiers, and solubilizers. These ingredients enhance product appeal and performance, making them indispensable in nutritional supplements and pharmaceuticals.

Stepans financials highlight its stability and growth potential, with a market cap of $1.4 billion. The trailing P/E of 31.17 and forward P/E of 16.75 suggest investor confidence in its future prospects. A P/B ratio of 1.15 indicates the companys assets are well-valued, while a P/S of 0.64 reflects efficient revenue generation relative to its market value.

Headquartered in Northbrook, Illinois, Stepans commitment to innovation and sustainability positions it as a leader in specialty chemicals. Its diverse product portfolio and strategic market presence make it an attractive consideration for investors seeking exposure to this sector.

Additional Sources for SCL Stock

SCL Stock Overview

Market Cap in USD 1,294m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception 1992-03-17

SCL Stock Ratings

Growth 5y -72.2%
Fundamental -4.26%
Dividend 61.3%
Rel. Strength -35.3
Analysts 3.5/5
Fair Price Momentum 36.85 USD
Fair Price DCF 128.93 USD

SCL Dividends

Dividend Yield 12m 2.54%
Yield on Cost 5y 1.74%
Annual Growth 5y 5.97%
Payout Consistency 100.0%

SCL Growth Ratios

Growth Correlation 3m -83.7%
Growth Correlation 12m -89%
Growth Correlation 5y -76.4%
CAGR 5y -12.29%
CAGR/Max DD 5y -0.19
Sharpe Ratio 12m -1.14
Alpha -46.14
Beta 0.819
Volatility 29.41%
Current Volume 136.5k
Average Volume 20d 123.6k
What is the price of SCL stocks?
As of April 09, 2025, the stock is trading at USD 45.26 with a total of 136,525 shares traded.
Over the past week, the price has changed by -16.48%, over one month by -21.87%, over three months by -26.45% and over the past year by -47.24%.
Is Stepan a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Stepan is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -4.26 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SCL as of April 2025 is 36.85. This means that SCL is currently overvalued and has a potential downside of -18.58%.
Is SCL a buy, sell or hold?
Stepan has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold SCL.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for SCL stock price target?
According to ValueRays Forecast Model, SCL Stepan will be worth about 39.9 in April 2026. The stock is currently trading at 45.26. This means that the stock has a potential downside of -11.82%.
Issuer Forecast Upside
Wallstreet Target Price 85 87.8%
Analysts Target Price 97 114.3%
ValueRay Target Price 39.9 -11.8%